Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Keyphrases

• Prospective Cohort Study 100%
• Rituximab 100%
• Systemic Sclerosis 100%
• Contemporary Practice 100%
• Skin Fibrosis 30%
• Lung 20%
• Propensity Score Matching 20%
• Forced Vital Capacity 20%
• Lung Fibrosis 20%
• Adverse Events 10%
• Clinical Practice 10%
• Randomized Trial 10%
• Safety Profile 10%
• Scleroderma 10%
• Steroid Use 10%
• Good Safety 10%
• Untreated Patients 10%
• Carbon Monoxide Diffusing Capacity 10%
• Skin Involvement 10%
• Mycophenolate Mofetil 10%
• Observational Design 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Prospective Cohort Study 100%
• Rituximab 100%
• Systemic Sclerosis 100%
• Skin Fibrosis 30%
• Lung Fibrosis 20%
• Prospective Study 10%
• Side Effect 10%
• Adverse Event 10%
• Carbon Monoxide 10%
• Mycophenolic Acid 10%
• Scleroderma 10%